Letters and Correspondence
暂无分享,去创建一个
[1] Daniel S. Holland,et al. A review of 76 patients with myelodysplastic syndromes treated with danazol , 1994, Cancer.
[2] L. Schwartz,et al. Gemcitabine‐related radiation recall preferentially involves internal tissue and organs , 2004, Cancer.
[3] D. Karcher,et al. The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation. , 1991, American journal of clinical pathology.
[4] A. Brandes,et al. Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three cases. , 2000, Anti-cancer drugs.
[5] A. Avilés,et al. Randomized study of danazol vs. placebo in myelodysplastic syndromes. , 1989, Archivos de investigacion medica.
[6] D. Fleming,et al. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. , 2000, Blood.
[7] M. Qazilbash,et al. Rituximab‐induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia , 2005, American journal of hematology.
[8] V. Ribrag,et al. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. , 2001, The New England journal of medicine.
[9] R. Camidge,et al. Characterizing the phenomenon of radiation recall dermatitis. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] S. Savaşan,et al. Liposomal Amphotericin B as Antifungal Prophylaxis in Bone Marrow Transplant Patients , 2006 .
[11] M. Markman,et al. Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy. , 2003, Gynecologic oncology.